A Clinical Trial to Evaluate the Immunogenicity and Safety of the 23-valent Pneumococcal Polysaccharide Vaccine in Healthy People

Clinical trial NCT06044077 · RECRUITING

Trial details

NCT number: NCT06044077
Sponsor: Aimei Vacin BioPharm (Zhejiang) Co., Ltd.
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Pneumococcal Disease

Start date: 2023-09-08
Primary completion: 2024-03-08
Enrollment: 1920

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.